Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
1.800
-0.085 (-4.51%)
Feb 5, 2026, 3:23 PM EST - Market open
Lyra Therapeutics Stock Forecast
LYRA's stock price has decreased by -78.94% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lyra Therapeutics stock has a target of 16, which predicts a 788.89% increase from the current stock price of 1.8.
Price Target: $16 (+788.89%)
Analyst Consensus: Hold
* Price targets were last updated on Aug 14, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Lyra Therapeutics is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $16 | Hold | Reiterates | $16 | +788.89% | Aug 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $2 → $16 | Hold | Maintains | $2 → $16 | +788.89% | Jun 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $100 | Hold | Reiterates | $100 | +5,455.56% | Mar 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $100 | Hold | Reiterates | $100 | +5,455.56% | Aug 15, 2024 |
Financial Forecast
Revenue This Year
658.92K
from 1.53M
Decreased by -57.05%
Revenue Next Year
1.73M
from 658.92K
Increased by 163.16%
EPS This Year
-26.17
from -71.75
EPS Next Year
-7.16
from -26.17
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 840,000 | 2.8M | ||||
| Avg | 658,920 | 1.7M | ||||
| Low | 392,000 | 686,000 |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -45.2% | 330.2% | ||||
| Avg | -57.0% | 163.2% | ||||
| Low | -74.4% | 4.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -26.94 | -7.37 | |
| Avg | -26.17 | -7.16 | |
| Low | -25.15 | -6.88 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.